Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...
The coming decades of space exploration hinge on a single, stubborn number: the 225 million kilometres between Earth and Mars ...